| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-05 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.19 | 8e-05 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.16 | 0.0004 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0006 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.16 | 0.0006 |